Blood filtering showdown: new hope for GBS patients?
NCT ID NCT04871035
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two blood-filtering treatments—immunoadsorption and plasma exchange—for people with Guillain-Barré syndrome (GBS), a rare nerve disorder that can cause muscle weakness and paralysis. Researchers will enroll 20 adults to see which method is safer and more effective at improving muscle strength and reducing disability. The goal is to find a better way to control the disease and speed up recovery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GBS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Neurology, University of Ulm
RECRUITINGUlm, Baden-Wurttemberg, 89081, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could targeted exercises rebuild strength after Guillain-Barré?
- Robot suit helps GBS patients take steps again
- Robots and VR join the fight to recover from nerve and muscle diseases
- New study seeks clues to help kids recover from Guillain-Barré
- Kids' hidden struggles after rare nerve disease revealed in new study
- Sound waves vs. nerve disease: a new way to spot GBS and CIDP?